Natural Products‐Based Anticancer Agents: Synthesis and Anticancer Activities of Funtumine Amide/Sulfonamide Derivatives

Abstract

Funtumine is a pregnene‐type steroidal alkaloid exhibiting moderate anticancer activity. To discover novel natural product‐based anticancer drugs, a series of novel funtumine amide/sulfonamide derivatives were papered and identified using spectroscopic techniques. Additionally, the structures of compounds 2j, 3a, and 4k were further confirmed through X‐ray diffraction analysis. Biological activity experiments conducted against three cancer cell lines revealed that several of the synthesized compounds demonstrated inhibition activities comparable to or exceeding those of the commercial anticancer agent, 5‐Fluorouracil. Especially compound 4i demonstrated a notably strong growth inhibitory effect on HePG2 (IC50 = 14.89 μM) and HCT116 (IC50 = 15.67 μM) cell lines, while exhibiting minimal cytotoxicity towards human normal BEAS‐2B cells. Preliminary structure‐activity relationships (SARs) analysis indicated that the conversion of the carbonyl group at the C‐20 position of funtumine to a hydroxyl group could yield more potent compounds.